SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - Nature

México Noticias Noticias

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - Nature
México Últimas Noticias,México Titulares
  • 📰 Nature
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 68%

Nature research paper: SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo

Emergence of SARS-CoV-2 variants of concern with progressively increased transmissibility between humans is a threat to global public health. The omicron variant also evades immunity from natural infection or vaccines, but it is unclear whether its exceptional transmissibility is due to immune evasion or intrinsic virological properties.

Kenrie P. Y. Hui, John C. W. Ho, Man-chun Cheung, Ka-chun Ng, Rachel H. H. Ching, Ka-ling Lai, Tonia Tong Kam, Haogao Gu, Leo L. M. Poon, Malik Peiris & Michael C. W. ChanKenrie P. Y. Hui, Leo L. M. Poon, Malik Peiris & Michael C. W. Chan Division of Cardiothoracic Surgery, Department of Surgery, Queen Mary Hospital, Pokfulam, Hong Kong SAR, ChinaDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Nature /  🏆 64. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

T cell responses to SARS-CoV-2 spike cross-recognize Omicron - NatureNature - T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Leer más »

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - NatureNature research paper: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Leer más »

Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron - NatureNature - Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
Leer más »

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipientsInfection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipientsA third dose of mRNA vaccine may be necessary to protect recipients of organ transplants from COVID19 and produce effective antibody responses against SARSCoV2, suggests a new immunological analysis of kidney transplant recipients. ScienceTM
Leer más »

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - NatureNature research paper: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Leer más »



Render Time: 2025-03-12 22:23:00